Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance.

× No keyword cloud information.

11 in total

1. Changes in the antigenicity of a hepatitis B virus mutant stemming from lamivudine therapy.

Authors: W N Chen; C J Oon
Journal: Antimicrob Agents Chemother Date: 2000-06 Impact factor: 5.191

2. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus.

Authors: W E Delaney; R Edwards; D Colledge; T Shaw; J Torresi; T G Miller; H C Isom; C T Bock; M P Manns; C Trautwein; S Locarnini
Journal: Antimicrob Agents Chemother Date: 2001-06 Impact factor: 5.191

Review 3. Drug delivery systems and liver targeting for the improved pharmacotherapy of the hepatitis B virus (HBV) infection.

Authors: María L Cuestas; Verónica L Mathet; José R Oubiña; Alejandro Sosnik
Journal: Pharm Res Date: 2010-03-24 Impact factor: 4.200

Review 4. Treatment of hepatitis B and C following liver transplantation.

Authors: Craig A Sponseller; Sanjay Ramrakhiani
Journal: Curr Gastroenterol Rep Date: 2002-02

Review 5. Lamivudine. A review of its therapeutic potential in chronic hepatitis B.

Authors: B Jarvis; D Faulds
Journal: Drugs Date: 1999-07 Impact factor: 9.546

Review 6. Clinical relevance of hepatitis B virus variants.

Authors: Shan Gao; Zhong-Ping Duan; Carla S Coffin
Journal: World J Hepatol Date: 2015-05-18

7. Failure of the lamivudine-resistant rtM204I hepatitis B virus mutants to efficiently support hepatitis delta virus secretion.

Authors: P T K Vietheer; H J Netter; T Sozzi; A Bartholomeusz
Journal: J Virol Date: 2005-05 Impact factor: 5.103

8. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.

Authors: L Fu; Y C Cheng
Journal: Antimicrob Agents Chemother Date: 2000-12 Impact factor: 5.191

9. Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B.

Authors: J Quarleri; F Moretti; M B Bouzas; N Laufer; M Gómez Carrillo; S Fernández Giuliano; H Pérez; P Cahn; H Salomon
Journal: AIDS Res Hum Retroviruses Date: 2007-04 Impact factor: 2.205

10. Molecular characterization of hepatitis B virus in blood donors in Botswana.

Authors: Wonderful T Choga; Motswedi Anderson; Edward Zumbika; Sikhulile Moyo; Tshepiso Mbangiwa; Bonolo B Phinius; Pinkie Melamu; Mukendi K Kayembe; Ishmael Kasvosve; Theresa K Sebunya; Jason T Blackard; Max Essex; Rosemary M Musonda; Simani Gaseitsiwe
Journal: Virus Genes Date: 2018-10-31 Impact factor: 2.332